Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Umeclidinium Bromide
Umeclidinium Bromide
  • Umeclidinium Bromide
  • Umeclidinium Bromide
  • Umeclidinium Bromide
  • Umeclidinium Bromide
  • Umeclidinium Bromide

Umeclidinium Bromide NEW

Price Get Latest Price
Package 1Kg/Bag 25Kg/Bag 100Kg/Bag
Min. Order: 1Kg/Bag
Supply Ability: 20 tons
Update Time: 2024-07-03

Product Details

Product Name: Umeclidinium Bromide CAS No.: 869113-09-7
EC-No.: 638-761-1 Min. Order: 1Kg/Bag
Purity: 0.99 Supply Ability: 20 tons
Release date: 2024/07/03

Product Information 

Product Name:Umeclidinium bromide
Synonyms:DIPHENYL-[1-(2-PHENYLMETHOXYETHYL)-1-AZONIABICYCLO[2.2.2]OCTAN-4-YL]METHANOL;BROMIDE;CS-1562;Umeclidinium bromide(GSK573719A);1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium Bromide;Umeclinidium bromide;GSK573719A;GSK-573719A;GSK 573719A;1-(2-(benzyloxy)ethyl)-4-(hydroxydiphenylmethyl)quinuclidin-1-ium bromide;GSK573719A
CAS:869113-09-7
MF:C29H34BrNO2
MW:508.48976
EINECS:638-761-1
Product Categories:API;869113-09-7
Mol File:869113-09-7.mol
Article illustration

Article illustration

Usage 


DescriptionUmeclidinium bromide is a long-acting muscarinic acetylcholine antagonist developed by GlaxoSmithKline and approved by the US FDA at the end of 2013 for use in combination with vilanterol, a b2 agonist, for the treatment of chronic obstructive pulmonary disease. Due to umeclidinium’s poor oral bioavailability, the drug is administrated by inhalation as dry powder.UsesUmeclidinium Bromide is considered as a potentially long-acting antimuscarinic agent.DefinitionChEBI: A quaternary ammonium salt that is the bromide salt of umeclidinium. Used in combination with vilanterol for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.SynthesisCommercially available ethyl isonipecotate (278) was alkylated with 1-bromo-2-chloroethane in the presence of K2CO3 in acetone to give ethyl 1-(2-chloroethyl)piperidine-4-carboxylate (279). This material was then treated with lithium diisopropylamine (LDA) in THF to affect a transannular substitution reaction resulting in the cyclized quinuclidine 280 in 96% yield. Excess of phenyllithium was added to ester 280 in THF starting at low temperature then gradually warming to room temperature to give tertiary alcohol 281 in 61% yield. Amine 281 was finally alkylated with benzyl 2- bromoethyl ether (282) in MeCN/CHCl3 at elevated temperatures to afford umeclidinium bromide (XXXV) in 69% yield.

Article illustration

references[1] salmon m, luttmann m a, foley j j, et al. pharmacological characterization of gsk573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases. journal of pharmacology and experimental therapeutics, 2013, 345(2): 260-270.

Article illustration

Company Profile Introduction

Sinoway Industrial co., ltd. was established in 1987 in Xiamen, China, and now has been a leading group specialized in research, development, custom manufacturing and trading of pharmaceutical intermediates, APIs, health and food supplements, cosmetic raw materials, herbal extracts, polypeptides and prostaglandin derivatives, etc.. We have passed ISO9001:2015. With qualified products, competitive price and excellent service, we have received great reputation of our customers from all over the world, including Southeast Asia, Europe, North America, South America, Middle East and other countries. We have over 20 years good partners in Japan、Korea and Switzerland. Sinoway has a professional R&D team. We have built close cooperative relationships with many research institutes and universities in China. Moreover, Sinoway combines market analysis with technology, providing new business trends to our clients. In addition, we have very close cooperation relationships with many Chinese pharmaceutical factories. These pharmaceutical manufacturers have GMP regulated workshops, advanced production and testing equipments, first-class QC labs and a production team with rich experience. We can supply various Active Pharmaceutical Ingredients and finished products which meet EP/USP/BP standards. Chinese GMP, EU-GMP, COS/CEP certificates with DMF documents are available, and many products have been approved by FDA. We believe that quality and innovation are vital for an enterprise. Adhering to the business philosophy of integrity and win-win cooperation, Sinoway is looking forward to have a bright future with you together.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$5.00/1KG
VIP1Y
Henan Fengda Chemical Co., Ltd
2024-04-16
$10.00/1kg
VIP1Y
Wuhan Xinhao Biotechnology Co., Ltd
2024-03-11
$0.00/1kg
VIP2Y
Hebei Kingfiner Technology Development Co.Ltd
2023-12-20
$70.00/1kg
VIP1Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-11-20
$10.00/1000g
Anhui Zhongda Biotechnology Co., Ltd
2023-10-18
$100.00/25kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-18
$0.00/25kg
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-06-01
$0.00/25KG
PNP Biotech Co. Ltd
2022-10-26
$10.00/1G
Lihe Pharm Technology(Wuhan)Co.,Ltd
2022-08-04
$30.00/1KG
Wuhan wingroup Pharmaceutical Co., Ltd
2022-04-02
  • Since: 1996-07-16
  • Address: Fujian China ,16F, Huicheng Comm. Complex, 839 Xiahe RD.
INQUIRY